India's ImmunoACT Gears To Deliver CAR-T Therapy At Close To Transplant-Like Prices

ImmunoACT hopes to provide affordable access to CAR-T cell therapy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia